Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jul 31, 2025 | (FY)Jul 31, 2024 | (FY)Jul 31, 2023 | (FY)Jul 31, 2022 | (FY)Jul 31, 2021 | (FY)Jul 31, 2020 | (FY)Jul 31, 2019 | (Q2)Jan 31, 2019 | (Q1)Oct 31, 2018 | (FY)Jul 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 42.91%106.74M | 11.91%74.7M | -38.16%66.75M | -14.62%107.94M | 153.29%126.42M | 7.38%49.91M | 4.89%46.48M | 12.27M | 5.60%11.62M | 3.16%44.31M |
| Cost of revenue | 43.34%79.54M | 3.44%55.49M | -26.38%53.64M | -2.80%72.87M | 93.72%74.96M | 8.13%38.7M | 3.00%35.79M | 9.47M | 6.65%8.47M | 11.80%34.75M |
| Gross profit | 41.64%27.21M | 46.56%19.21M | -62.63%13.11M | -31.84%35.08M | 358.84%51.46M | 4.87%11.21M | 11.77%10.69M | 2.8M | 2.87%3.15M | -19.44%9.57M |
| Operating expense | 23.92%13.15M | -21.50%10.61M | 104.23%13.51M | -4.89%6.62M | 45.12%6.96M | -24.73%4.79M | 68.21%6.37M | 1.15M | 2.71%1.1M | 0.36%3.79M |
| Selling and administrative expenses | 23.92%13.15M | -32.21%10.61M | 82.03%15.65M | 2.43%8.6M | 56.86%8.39M | -15.99%5.35M | 55.29%6.37M | --1.15M | 2.71%1.1M | 106.29%4.1M |
| -Selling and marketing expense | ---- | 12.00%865.39K | -0.15%772.64K | 21.75%773.77K | 30.31%635.56K | -9.92%487.74K | 69.32%541.44K | ---- | 63.95%141K | -26.90%319.77K |
| -General and administrative expense | 23.92%13.15M | -28.69%10.61M | 90.15%14.88M | 0.85%7.82M | 59.52%7.76M | -16.55%4.86M | 54.10%5.83M | --1.29M | -2.64%960K | 143.85%3.78M |
| Total other operating income | ---- | -40.66%1.27M | 7.83%2.14M | 37.90%1.98M | 157.85%1.44M | --557K | ---- | ---- | ---- | 49.29%315.01K |
| Operating profit | 63.51%14.06M | 2,204.59%8.6M | -101.44%-408.58K | -36.05%28.46M | 593.11%44.5M | 48.47%6.42M | -25.20%4.32M | 1.65M | 2.96%2.05M | -28.66%5.78M |
| Net non-operating interest income (expenses) | -4.51%-2.96M | -0.67%-2.84M | -96.62%-2.82M | -86.10%-1.43M | -13.54%-769.92K | 25.09%-678.08K | -85.86%-905.17K | -224K | -36.47%-116K | -11.01%-487.03K |
| Non-operating interest expense | 4.51%2.96M | 0.67%2.84M | 96.62%2.82M | 86.10%1.43M | 13.54%769.92K | -25.09%678.08K | 85.86%905.17K | --224K | 36.47%116K | 9.27%487.03K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -55.72%561K | 1.27M | 413.26K | 51K | 330.23%185K | |||||
| Income before tax | 65.82%11.66M | 317.93%7.03M | -111.94%-3.23M | -38.20%27.03M | 661.55%43.73M | 49.84%5.74M | -27.62%3.83M | 1.48M | 8.72%2.12M | -32.69%5.29M |
| Income tax | -16.91%1.48M | 360.31%1.79M | -122.66%-686.11K | -56.28%3.03M | 469.72%6.92M | 71.80%1.22M | 28.89%707.39K | 60K | -66.46%214K | -31.41%548.82K |
| Net income | 93.99%10.17M | 306.48%5.24M | -110.58%-2.54M | -34.80%24M | 713.05%36.81M | 44.87%4.53M | -34.15%3.12M | 1.42M | 45.27%1.91M | -32.83%4.75M |
| Net income continuous operations | 93.99%10.17M | 306.48%5.24M | -110.58%-2.54M | -34.80%24M | 713.05%36.81M | 44.87%4.53M | -34.15%3.12M | --1.42M | 45.27%1.91M | -32.83%4.75M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 93.99%10.17M | 306.48%5.24M | -110.58%-2.54M | -34.80%24M | 713.05%36.81M | 44.87%4.53M | -34.15%3.12M | 1.42M | 45.27%1.91M | -32.83%4.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 93.99%10.17M | 306.48%5.24M | -110.58%-2.54M | -34.80%24M | 713.05%36.81M | 44.87%4.53M | -34.15%3.12M | 1.42M | 45.27%1.91M | -32.83%4.75M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 93.42%0.0294 | 308.22%0.0152 | -110.53%-0.0073 | -34.81%0.0693 | 711.45%0.1063 | 25.96%0.0131 | -34.18%0.0104 | 0.0058 | 45.27%0.0055 | -22.55%0.0158 |
| Diluted earnings per share | 93.42%0.0294 | 308.22%0.0152 | -110.53%-0.0073 | -34.81%0.0693 | 711.45%0.1063 | 25.96%0.0131 | -34.18%0.0104 | 0.0041 | 45.27%0.0055 | -22.55%0.0158 |
| Dividend per share | 218.18%0.0035 | -35.29%0.0011 | -66.00%0.0017 | 233.33%0.005 | -40.00%0.0015 | 0.0025 | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.